CoChat

Orforglipron (LY3502970), a novel, oral non‐peptide glucagon‐like peptide‐1 receptor agonist: A Phase 1b, multicentre, blinded, placebo‐controlled, randomized, multiple‐ascending‐dose study in people with type 2 diabetes

Open access
Pratt, Edward · 2024 · Diabetes, Obesity and Metabolism
Cited by 18

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Dear Editor, We wish to clarify differences between figure 3 of the main manuscript (Body weight change from baseline at week 12) and table S3 (Summary of pharmacodynamic parameters at baseline and week 12)—specifically that the least squares mean (LSM) change from baseline body weight values shown in figure 3 are different than the implied weight change values indicated in table S3 across all orforglipron doses, when subtracting the LSM of body weight at baseline and week 12.1 We can clarify that the differences between the values shown in figure 3 and table S3 are because of the differences in the analysis model. The LSMs presented in figure 3 reflect the analysis from a linear mixed model with change from baseline as the response, while table S3 represents data from a model with actual values at week 12 as the response. For the change from baseline analysis, an unstructured covariance structure was used (figure 3), while for the actual weight values (table S3), there were model convergence issues when the same covariance structure was attempted and, therefore, a compound symmetry covariance structure was applied. With this subtle difference, the treatment differences are slightly different between the two analyses. The study pre-specified analysis for the treatment comparison is based upon the change from baseline (figure 3), and thus it is recommended that readers use this for interpreting the treatment effects. The peer review history for this article is available at https://www.webofscience.com/api/gateway/wos/peer-review/10.1111/dom.15372.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/dom.15372

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 18

Metadata

Authors
Pratt, E.
Venue
Diabetes, Obesity and Metabolism
Publisher
Wiley
Published
2023-11-23
Volume
26
Issue
3
Pages
1137-1137
ISSN
  • 1462-8902 (ISSN-L)
  • 1463-1326
OpenAlex
W4388976659
Cited by
18
References
1
FWCI
2.98
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.